Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 14 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-29 4 AS $82.67 $688,972 D/D (8,334) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-17 4 AS $84.54 $676,320 D/D (8,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-18 4 AS $85.08 $595,560 D/D (7,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-19 4 AS $83.58 $585,060 D/D (7,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-11 4 AS $77.68 $543,760 D/D (7,000) 295,652 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-12 4 AS $77.10 $539,700 D/D (7,000) 295,652 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-22 4 AS $78.91 $789,100 D/D (10,000) 302,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-23 4 AS $79.34 $793,400 D/D (10,000) 302,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-06 4 AS $78.01 $1,957,199 D/D (25,000) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-07 4 AS $77.60 $1,953,121 D/D (25,000) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-10 4 AS $77.29 $657,970 D/D (8,513) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-15 4 AS $82.71 $496,260 D/D (6,000) 303,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-16 4 AS $84.68 $508,080 D/D (6,000) 303,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-12 4 AS $89.00 $445,000 D/D (5,000) 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-13 4 AS $87.86 $439,300 D/D (5,000) 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-10 4 AS $77.57 $1,163,550 D/D (15,000) 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-11 4 AS $77.81 $1,167,150 D/D (15,000) 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-14 4 AS $83.66 $836,600 D/D (10,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-18 4 AS $81.91 $1,638,200 D/D (20,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-28 4 AS $83.79 $1,675,800 D/D (20,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-29 4 AS $81.95 $409,750 D/D (5,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-05 4 AS $84.14 $841,400 D/D (10,000) 335,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-06 4 AS $81.00 $1,620,000 D/D (20,000) 335,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-08-12 4 AS $94.75 $379,000 D/D (4,000) 331,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-08-15 4 AS $95.21 $285,630 D/D (3,000) 328,324 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14  15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 14 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us